32.6 C
Vientiane
Friday, October 10, 2025
spot_img
Home Blog Page 117

RD Technologies Group Announces Brand Enhancement with Launch of new Cross-Border Payment Brand “OristaPay”

HONG KONG, Sept. 29, 2025 /PRNewswire/ — RD Technologies Group (“the Group”) today announced a strategic brand enhancement initiative with the official launch of a new cross-border payment brand, “OristaPay.” This move clearly differentiates the Group’s two core business segments: firstly, OristaPay dedicated to cross-border payment services consisting of fiat wallet and payment services, which are operated by RD Wallet Technologies Limited (RDWT), a Stored Value Facility (SVF) licensee and digital payment and custody services, which are provided by RD Escrow, a licensed TCSP and other relevant licenses held by its subsidiaries; and secondly, RD InnoTech Limited, an independently operated entity that participated in the Hong Kong Monetary Authority’s (HKMA) Stablecoin Issuer Sandbox in July 2024.

Under the enhancement, “OristaPay” is positioned as a leading next-generation payment infrastructure provider. With RDWT’s SVF licence and other relevant licenses, it delivers secure, compliant, efficient, and innovative cross-border payment solutions for corporate clients, combining compliance strengths with technological innovation. Meanwhile, RD InnoTech Limited remains dedicated to supporting the evolution of Hong Kong’s regulatory framework for stablecoins and actively engaging in compliant fintech practices.

The two business segments will operate independently under a strategy of synergistic development, each pursuing distinct market opportunities while collectively advancing the Group’s leadership in the digital finance sector.

Rita Liu, CEO of RD Technologies Group, stated, “A clear brand strategy will better unlock the core potential of each business. RD Technologies Group has been committed to compliant innovation for five years, and we firmly believe that technology will bring customers superior and more efficient payment and financial solutions. Through our two core business segments, we look forward to continuing creating value for clients from different perspectives within the finance and payment industry, while also contributing to Hong Kong’s fintech innovation.”

About RD Technologies Group

RD Technologies Group is a Hong Kong-based fintech group with a global outlook, providing innovative digital financial services for corporate clients through its diversified licensed entities. The Group is committed to building next-generation financial infrastructure that connects traditional finance (Web2) and Web3. Leveraging Hong Kong’s position as an international financial center, the Group combines technological innovation with compliance best practices to offer secure, efficient, and transparent cross-border payment, digital asset management, and settlement services. RD Technologies Group actively participates in the development of Hong Kong’s virtual asset regulatory framework, supporting the Hong Kong Monetary Authority and other regulators to drive innovation in stablecoins, cross-border payments, and compliance infrastructure, helping Hong Kong’s goal of becoming a leading digital finance and virtual asset hub in Asia. Learn more: https://rd.group

About OristaPay

OristaPay is a new cross-border payment brand under RD Technologies Group. It specializes in providing payment solutions for corporate clients, consisting of the stored value facilities (SVF) license and other relevant licenses held by different Group subsidiaries to ensure secure and fully compliant operations.

ONYX Hospitality Group Positions Shama Serviced Apartments as a Premier Choice for Health and Wellness Travellers

With prime city locations and unparalleled convenience, Shama offers the perfect rejuvenating retreat to meet the growing demand for medical and wellness tourism.


BANGKOK, THAILAND – Media OutReach Newswire – 29 September 2025 – ONYX Hospitality Group, a leading hospitality management company with a portfolio spanning hotels, resorts, serviced apartments, and luxury residences, is capitalising on the rapid growth of medical and wellness tourism through the expansion of its serviced apartment brand, Shama. Designed to meet the evolving needs of health-focused travellers, Shama provides an ideal blend of comfort, convenience, and care—making it the preferred choice for both short- and long-term stays.

Shama Petchburi 47 Bangkok Two Bedroom Suite Living Room Washing and drying machine 2

Mr. Yuthachai Charanachitta, CEO of ONYX Hospitality Group, commented “With the continued growth of health and wellness tourism, Thailand remains a preferred destination for domestic and international travellers. The country offers unrivalled advantages, from ease of accessibility and natural beauty to the nutritional value of Thai cuisine and the health benefits of traditional Thai herbs. Added to this is a comprehensive wellness industry encompassing physical and mental health, nutrition, spa, and beauty services—all of which present significant opportunities for ONYX to develop and expand our offerings. Through Shama, we are able to deliver accommodation that complements the lifestyles of today’s wellness-conscious guests, who increasingly prioritise their health and wellbeing.”

Shama as the Cornerstone of ONYX’s Wellness Strategy

At the heart of this strategy is Shama, ONYX’s dedicated serviced apartment brand. Each residence is thoughtfully designed with spacious, well-proportioned layouts that offer both comfort and privacy, ensuring guests feel at home whether staying for days, weeks, or months. Shama’s prime city locations further enhance its appeal for wellness tourists seeking proximity to world-class medical services alongside a high standard of living and relaxation.

Market Growth and Opportunity

Thailand’s medical and wellness tourism market continues to grow at pace, fuelled by the government’s Medical & Wellness Hub policy. According to Global Market Insights Inc., the sector is forecast to reach USD 31.5 billion in 2024, with projections of USD 110.1 billion by 2034. Medical travellers—those visiting for treatment or health services—often combine their care with leisure and recuperation, favouring extended stays in comfortable, home-like accommodation. This trend positions serviced apartments as an ideal solution.

Mr. Yuthachai added:

“This segment of travellers typically stays in Thailand for several weeks or months. They require practical, home-like living with comprehensive amenities and services. Shama caters perfectly to these needs, offering city-centre locations, many within walking distance of major hospitals, with spacious apartments and 24-hour, hotel-standard care—making them an excellent choice for recuperation and long-term wellness stays.”

Prime Locations for Medical Travellers

Shama’s Bangkok properties are strategically positioned to serve this segment:

  • Shama Petchburi 47 Bangkok – Adjacent to Bangkok Hospital and just minutes from Piyavate Hospital, in a peaceful yet accessible neighbourhood.
  • Shama Sukhumvit Bangkok – A tranquil city-centre retreat with gardens and family-friendly amenities, only a short walk from Bumrungrad International Hospital.
  • Shama Yen-Akat Bangkok – Located between Silom and Sathorn, two of Bangkok’s busiest business districts.
  • Shama Ekamai Bangkok – Nestled in the lively Ekkamai–Thonglor area, surrounded by retail, dining, and lifestyle options.
  • Shama Lakeview Asoke Bangkok – Overlooking Benjakitti Park, offering a serene atmosphere with excellent connectivity to city conveniences.

Looking ahead to 2025, ONYX will further strengthen its presence with Shama 101 Bangkok, strategically located near Punnawithi and Bangchak BTS stations in a vibrant business and residential district.

Beyond Health Tourism

While Shama’s locations are particularly attractive to wellness and medical travellers, its residences cater to a wide range of guests, from solo business travellers to extended families seeking a “second home”. The brand is segmented into three distinct tiers—Shama Luxe, Shama, and Shama Hub—each offering varied designs, sizes, and locations to meet the needs of upper-upscale through to upper-middle-scale travellers.

Currently, Shama operates six properties in Thailand, along with 12 in China and Hong Kong and two in Malaysia, with further expansion planned both domestically and across international markets.

For more information about ONYX Hospitality Group, visit www.onyx-hospitality.com. To learn more about Shama, visit www.shama.com

Hashtag: #ONYX

The issuer is solely responsible for the content of this announcement.

Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion

— ARK Invest makes its first direct move into APAC equities in a financing round led by SIG-affiliate CVI Investment with IAM’s participation in the formation of a global “Dream Team” to propel Tokyo-listed Quantum Solutions

TOKYO, Sept. 29, 2025 /PRNewswire/ — Quantum Solutions Co., Ltd. (Tokyo Stock Exchange Code: 2338.T, “Quantum”) announced its strategic financing initiative on September 26 to issue 44 million shares to a blue-chip investor mix of three heavyweight institutions, providing the necessary permanent capital and network access to position Quantum as a potential frontrunner in the world of Ethereum (ETH) listed strategies and a showcase standout in the Tokyo stock market.

For Japanese investors, this represents another significant commitment by leading US capital, following Warren Buffett’s investment in Japan’s five major trading companies. For international investors, it signals that Tokyo’s stock market is an increasingly attractive destination for global capital, welcoming new opportunities for “smart money”.

Dream Team of Global Capital Aligns for Quantum, International Demand for Japanese Equities Continues to Grow

Quantum’s investor line-up is a market stunner in the emerging field of crypto-linked equities. Susquehanna International Group (SIG), investing via CVI Investments, holds the capital firepower to accelerate Quantum’s ETH accumulation and expand its balance sheet for upcoming fundraising rounds. With a portfolio that includes early investments in ByteDance and Strategy Inc. (NASDAQ: MSTR), SIG is a Tokyo Stock Exchange participant, offering the robust capital infrastructure that analysts consider essential for a successful Digital Asset Treasury (DAT).

Cathie Wood affirms her position as the world’s leading investor in crypto-linked equities with ARK Invest’s first direct foray into APAC-listed opportunities. In the US market, ARK has a track record for identifying category leaders such as ETH Treasury Bitmine Immersion Technologies (NYSE: BMNR) and cryptocurrency exchange Coinbase (NASDAQ: COIN). By adding Quantum, Wood extends her expertise to the Tokyo market, bringing visibility to Quantum in front of the global investing audience as the region’s most promising ETH Treasury initiative.

The third participant is Hong Kong-based Integrated Asset Management (IAM), led by Mr. TC Yam. As the majority shareholder of Forbes Media, IAM’s cross-sector presence in international finance and media resources bolsters Quantum’s capital depth and reputational standing. Like ARK, IAM makes its first public investment in the Tokyo stock market, signaling growing confidence among global institutional investors in Japan’s equity market.

The fundraise utilizes convertible bonds and both floating and fixed strike price warrants for a total issuance of approximately 44 million shares, nearly doubling the company’s existing share capital. None of the instruments are priced at a discount, a rarity for DAT fundraises, suggesting that the incoming investors are targeting long-term growth prospects. As of market closing on September 26, the nominal value of the financing round comes to over JPY 26 billion (approx. USD 180 million), with the first tranche valued at JPY 22.1 billion (approx. USD 150 million).

First ETH Treasury in Japan — A Differentiated Strategy Offering Long-Term Returns on Equity

According to research reports by leading investment banks, the key determinants of success for listed Digital Asset strategies are robust access to capital and a team with operational blockchain expertise. Through this fundraising initiative, Quantum taps into fresh sources of capital and aligns with investors of strong reputation, prompting market expectations of long-term backing.

Quantum CEO Francis B. Zhou is no newcomer to the Digital Asset industry, as one of the first institutional investors and operators in the blockchain space. In 2018, Zhou acquired the world’s second largest ETH mining facility, based in Jokkmokk, Sweden. Zhou maintains investments in early stage blockchain projects alongside film and IP holdings in his venture investment portfolio, and brings a network of experienced blockchain operators, including Head of Crypto Strategy Donny Chi.

Proceeds from Quantum’s financing initiative will be used to accumulate ETH. Although BTC has demonstrated adoption as a store-of-value, ETH is the foundational asset for blockchain applications, enabling companies like Quantum to explore attractive yield-generating opportunities to drive a blend of organic and inorganic growth for the company’s core treasury and balance sheet.

The appeal of yield-bearing strategies is supported by data from the US market, which indicates that listed ETH Treasuries trade at a price-to-book multiple of 7.72x, more than 3 times higher than that of listed BTC Treasuries. More remarkably, the price-to-book of ETH Treasuries is trending upwards, increasing by over 20% within the trading month of September, demonstrating that the market expectations continue to strengthen for listed ETH Treasuries as it relates to long-term returns on equity.

Zhou and the Quantum Solutions team have a history of exploring growth frontiers, consequently developing industry traction in AI computing, GPU hosting, and IP gaming. This positions the company to pursue unique opportunities beyond overcrowded sectors in Real World Asset (RWA) space to potentially generate more attractive returns.

With the fundraise, Quantum’s notional price-to-book multiple is estimated to be less than 30% of the market median. Assuming that the company can reach its fair value, the structure of the fundraise allows the company to rapidly accelerate its capital accumulation to reach the target of 100,000 ETH within the near term, positioning Quantum among the leading ETH Treasury companies globally.

Growth Driven Policies in Japan Encourage Prospects for Long-Term Shareholder Value

Consistent government support for the blockchain industry and increasing clarity in regulations are ushering in a more investor-friendly market for Digital Assets in Japan. Whereas the US market already has ETH Treasury companies such as Bitmine (NASDAQ: BMNR) and SharpLink Gaming (NASDAQ: SBET) achieving significant market cap growth as capital market highlights, Japan lacks a similar listed benchmark. Quantum Solutions’ entry fills this gap, opening a new chapter as “Japan’s first”, and creating conditions for capital inflow and renewed market participation.

This financing round, nominally valued at approximately USD 180 million, is a landmark in both the Japanese stock market as well as the crypto-linked equities space. Through the combined endorsement of SIG, ARK, and IAM, Quantum not only secures funding but also international validation under a capital structure optimized to maximize long-term shareholder value. High-profile deals of this caliber further Tokyo as an emerging destination for savvy investors.

2025 China International Online Literature Week Opens in Hangzhou

BEIJING, Sept. 29, 2025 /PRNewswire/ — The 2025 China International Online Literature Week kicked off on September 26 in Hangzhou, Zhejiang Province, highlighting how artificial intelligence is reshaping digital storytelling.

 

2025 China International Online Literature Week Opens in Hangzhou

Held under the theme “New Momentum, New Landscape, New Dimension: Global Vision of AI-Empowered Online Literature,” the opening gathered representatives from 19 countries, including foreign embassy officials, overseas authors and readers, and experts in translation and international communication. They joined Chinese online writers, platform executives and critics for discussions on the growing global influence of online literature.

In recent years, Chinese online literature has accelerated its mainstreaming and pursuit of high-quality production, shaping a vibrant new scene for Chinese literature in the digital era. It has ignited boundless creativity and innovation among the public, serving as a vital and representative platform for new popular culture. This dynamic medium showcases the immense vitality and limitless potential of contemporary literature. Moreover, online literature has emerged as a key vehicle for promoting Chinese culture globally, making a unique contribution to the creation of new global cultural forms.

At the opening ceremony, the China Writers Association Online Literature Center released the China Online Literature International Communication Report 2025, which comprehensively reviews the global outreach and development of online literature in 2024, vividly outlining its evolving landscape. A four-party cooperation framework agreement was signed between the China Writers Association Online Literature Center, the Chinese Literature Foundation, the Zhejiang Writers Association, and the Publicity Department of the CPC Hangzhou Municipal Committee. The event also launched the “Initiative to Promote the International Communication of Online Literature”, the “Beautiful China International Writing Program”, and the “Measures of Hangzhou City to Support the Prosperous Development of Online Literature”.

The 2025 International Online Literature Week will also feature a range of events, including the Online Literature International Roundtable, Online Literature Lectures at Universities, International Exchanges and Dialogues, and Online Literature Going Global Business Forum. These activities aim to harness the widespread and international appeal of online literature to promote its global reach.

Collect Iconic Character Merch on Your Phone! New App “Hello Kitty Merch Match” Officially Launches in 144 Countries and Regions Today

TOKYO, Sept. 29, 2025 /PRNewswire/ — Applibot, Inc. (Headquarters: Shibuya, Tokyo; President: Koki Ukita), a consolidated subsidiary of CyberAgent Inc. (Headquarters: Shibuya, Tokyo; President: Susumu Fujita), announced the official global launch of “Hello Kitty Merch Match” today, Monday, September 29, 2025. The game is now available in 144 countries and regions worldwide.

Hello Kitty Merch Match_release
Hello Kitty Merch Match_release

Hello Kitty Merch Match is a 3D puzzle game, offering simple, accessible gameplay where players find and tap on three matching Sanrio character merchandise items to clear the stages. The game features over 1,000 different Sanrio character items that players of all ages can enjoy collecting while exploring an extensive virtual collection that includes everything from nostalgic collectibles to the latest releases.

Game Images
Game Images

© ’25 SANRIO CO., LTD. APPR. NO. G660083

Hello Kitty Merch Match Overview

  • Title: Hello Kitty Merch Match
  • Genre: 3D Match Puzzle Game
  • Release Date: September 29, 2025
  • Price: Free to play (In-app purchases available)
  • Supported OS: iOS/Android (Availability may vary by device model)
  • Developer and Operator: Applibot, Inc.
  • Copyright: © ’25 SANRIO CO., LTD. APPR. NO. G650141 © Applibot, Inc.

Official Links
App Store: https://apps.apple.com/app/id6740388983
Google Play:
https://play.google.com/store/apps/details?id=jp.co.applibot.HelloKittyMerchMatch
Official Website: https://hellokittymerchmatch.com/en
Official X (Formerly Twitter): https://x.com/HKMerchMatch
Concept Video: https://www.youtube.com/watch?v=2hUDcSbWQ9k

About Hello Kitty Merch Match

“Hello Kitty Merch Match” is a 3D puzzle game featuring over 1,000 pieces of Sanrio character merchandise. With simple rules—just tap three matching items to clear them from the board—the game offers an easy, enjoyable experience for all ages. Players can collect everything from nostalgic merch to the latest goods, appealing to a wide audience across generations. The game officially launched in 144 countries and regions on September 29, 2025.

Bridging Capital and Opportunity: Huatai Securities Fuels Chinese Firms’ Global Expansion at China-Singapore Cross-Border Talks


HONG KONG SAR & SINGAPORE – Media OutReach Newswire – 29 September 2025 Against the backdrop of a global hunt for yield and strategic diversification, the China–Singapore Cross-Border Investment and Financing Conference and Investor Exchange (the “Conference”) was recently held in Singapore, co‑hosted by the China Association for Public Companies and the Bank of China Singapore Branch. Huatai Securities, together with other institutions, served as an organizer for the third consecutive year – underscoring the Company’s ongoing commitment and capabilities to fueling cross-border investment and financing collaboration for Chinese enterprises.

The event brought together 20 A‑share listed companies spanning consumer electronics, information technology, biomedicine, and advanced manufacturing — all presenting roadshows to institutional investors keen to gauge China’s investment narrative as it evolves.

The Conference featured keynote addresses from PAN Guangbiao, Council Member of the China Association for Public Companies (CAPCO); HU Wei, Deputy General Manager of the Bank of China Singapore Branch; Dr. LIANG Hong, Chairperson of the Institutional Business Committee at Huatai Securities; and Chia Caihan, Head of Greater China Capital Markets of Singapore Exchange Limited (SGX Group). They were joined by senior executives from Southern Asset Management, and representatives of listed companies to explore actionable opportunities for cross-border investment and financing between China and Singapore.

Revaluing China: Market Seize the Moment

The Conference highlighted the ongoing revaluation of Chinese assets. Bank of China Singapore Branch Deputy GM HU Wei opened with a reaffirmation: China’s robust economic fundamentals, consistent policy steer, and the resilience of its A‑share market are sharpening the country’s appeal as a core allocation for global investors.

Dr. LIANG Hong, Chairperson of Huatai Securities Institutional Business Committee reviewed the trajectory of this revaluation in her speech, citing the policy-driven market rebound in September 2024, the tech-stock repricing in early-2025, and the broader asset revaluation observed in recent months. Dr. LIANG pointed that with a stable infrastructure backbone, an unmatched engineering talent pool, and a vast domestic market, China has every reason – with its inherent capabilities – to command a fresh look from global capital.

Dr. LIANG added that with the US Federal Reserve easing cycle now looming, macro narratives are being rewritten. A weaker dollar could invite RMB appreciation expectations, amplifying the allure of Chinese assets — notably Hong Kong equities — for international investors.

Huatai’s Expanding CrossBorder Playbook

In a year where Asia’s capital flows are rewriting regional dynamics, Huatai has moved decisively and consistently to widen its execution capabilities in cross-border businesses.

First half of 2025: Huatai Securities (Singapore) secured Issue Manager license on Singapore Exchange (SGX), strengthening its onshore facilitation role.

July 2025: It obtained Foreign Portfolio Investor (FPI) registration from the Securities and Exchange Board of India (SEBI), green‑lighting its entry into the Indian capital markets.

These strategic licenses extend Huatai’s reach across Southeast Asia and beyond, complementing its record this year as a lead underwriter, delivering successful Hong Kong and mainland IPOs for Chinese corporates, and leveraging a fully integrated onshore–offshore service model.

“Our aim with this summit is to embed technology as well as industrial innovation and collaboration more deeply into the China–Singapore financing conversation exploring new solutions for cross-border investment and financing,” Dr. LIANG said, “and to encourage sustained, high‑quality engagement between overseas capital and China’s best‑in‑class listed companies.”

Spotlight on Collaboration and Competitiveness

Among corporate keynotes, WU Sanqiang, Board Secretary of China International Marine Containers (CIMC Group), positioned continued capital market reform, deeper participation in global value chains, and the emerging “Singapore+1” strategic model as catalytic forces enhancing Chinese firms’ international competitiveness.

XIAN Weiwei, Senior Vice President of Sustainable Development Department at Southern Asset Management and XIE Dongming, Managing Director of Oversea-Chinese Banking Corporation (OCBC) made their speeches regarding sustainable investment and cross-border finance cooperation.

The agenda also featured a standout panel discussion titled “Cracking the Investment Code: Resilience and Growth Engines in China’s Transforming Economy”, which brought together Huatai Securities’ Chief Analyst for Energy Transformation Research, LIU Jun, and other representatives of listed companies to explore emerging investment opportunities through a round table discussion.

Capital Bridges Built for the Long Term

The event concluded with investor pitches involving 20 invited listed companies, alongside a parallel forum hosted by the Bank of China focused on cross‑border financing and corporate internationalization. These sessions provided direct platforms for dialogue and partnership, reinforcing capital connectivity and industrial collaboration between Chinese companies and the dynamic Southeast Asian market.

Hashtag: #HuataiSecurities

The issuer is solely responsible for the content of this announcement.

About Huatai Securities

Incorporated in April 1991, Huatai Securities is a leading technology-driven securities group in China, with a highly collaborative business model, a cutting-edge digital platform and an extensive and engaging customer base. It provides comprehensive financial services to individual and institutional clients, including wealth management, investment banking, sales and trading, investment management, among others, with a substantial international presence.

Shama Serviced Apartments: A Home-Style Escape in the Heart of Bangkok


BANGKOK, THAILAND – Media OutReach Newswire – 29 September 2025 – In a buzzing, fast-paced city like Bangkok, travellers are increasingly seeking a space that feels like home. Shama, the serviced apartment brand from ONYX Hospitality Group — a leading hospitality management company with a portfolio spanning hotels, resorts, serviced apartments, and luxury residences — offers the perfect solution. Centrally located, Shama residences combine modern convenience with tranquillity, allowing guests to work, relax, and unwind in a peaceful, thoughtfully designed, home-like environment tucked away from the city’s usual hustle.

Stay Well

Shama creates an environment that balances the dynamism of urban life with the warmth of home, allowing guests to embrace each moment harmoniously. Every apartment is designed as a genuinely liveable space—spacious, light-filled, and comfortable—with well-proportioned layouts and a full suite of amenities, including a kitchen, living room, housekeeping service, concierge, fitness centre, and swimming pool. These features ensure that residents feel truly at home, whether staying for a short visit or a long-term stay.

All Shama properties occupy prime locations, offering seamless access to both business hubs and lifestyle destinations. Through initiatives such as the Shama Social Club and Shama Friends, residents are invited to join a diverse range of activities designed to foster community connections, enhance lifestyles, and enrich day-to-day living.

For example, Shama Yen-Akat Bangkok lies between the bustling commercial districts of Silom and Sathorn; Shama Ekamai Bangkok is set in the vibrant Ekkamai–Thonglor neighbourhood with its array of shopping and dining options; while Shama Lakeview Asoke Bangkok provides a peaceful retreat near Benjakitti Park, with effortless access to the city’s conveniences.

Shama also offers strategically located properties for those wishing to stay close to leading hospitals, whether to support loved ones or as health tourists seeking a restful environment for recovery. Shama Petchburi 47 Bangkok sits in a quiet yet accessible neighbourhood adjacent to Bangkok Hospital; Shama Sukhumvit Bangkok, just five minutes from Piyavate Hospital, combines a central-city location with lush gardens and family-friendly amenities; while Bumrungrad International Hospital is only a short stroll away.

The Shama portfolio comprises three distinct offerings—Shama Luxe, Shama, and Shama Hub—each tailored to suit the lifestyles of upper-upscale to upper-middle-class travellers.

Currently, Shama operates six prime properties across Thailand, 12 across China and Hong Kong, and two in Malaysia, with ambitious expansion plans both domestically and internationally.
Hashtag: #ONYX

The issuer is solely responsible for the content of this announcement.

Viva Biotech Receives Frost & Sullivan’s 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem.

SAN ANTONIO, Sept. 29, 2025 /PRNewswire/ — Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated Intelligent Drug Discovery industry for its outstanding achievements in driving transformative efficiencies in preclinical research and development. This recognition highlights Viva Biotech’s consistent leadership in combining artificial intelligence with laboratory-driven validation to reshape the future of drug discovery, strengthen client partnerships, and deliver scalable innovation in a highly competitive landscape.

This recognition highlights Viva Biotech’s consistent leadership in combining artificial intelligence with laboratory-driven validation to reshape the future of drug discovery, strengthen client partnerships, and deliver scalable innovation in a highly competitive landscape.
This recognition highlights Viva Biotech’s consistent leadership in combining artificial intelligence with laboratory-driven validation to reshape the future of drug discovery, strengthen client partnerships, and deliver scalable innovation in a highly competitive landscape.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution.

Viva Biotech excelled in both, demonstrating an ability to align advanced technologies with client demand, precisely and at scale. “By integrating multimodal artificial intelligence with extensive wet lab validation, Viva Biotech has established one of the most versatile discovery platforms in the industry. Its ability to support diverse modalities—from small molecules and antibodies to emerging therapies such as PROTACs, molecular glues, and RNA-targeting compounds—significantly reduces development timelines and costs for global clients,” said Priyanka Jain, senior research analyst at Frost & Sullivan.

Guided by a long-term growth strategy that emphasizes digital innovation, client partnerships, and operational efficiency, Viva Biotech has demonstrated remarkable agility in adapting to the evolving pharmaceutical research landscape. The company’s investment in AI-driven modeling, structure-based drug discovery, and seamless lab-in-the-loop systems has enabled it to accelerate decision-making and support first-in-class as well as fast-follow programs for clients worldwide.

Innovation is central to Viva Biotech’s approach. Its Artificial Intelligence-Driven Drug Discovery (AIDD) platform, comprising proprietary modules V-Scepter, V-Orb, and V-Mantle, addresses longstanding drug design challenges by combining predictive modeling, physics-based simulations, and generative AI. These tools are directly integrated with wet lab experimentation, allowing for rapid validation and iterative refinement of drug candidates. “We are very honored to receive this award from Frost & Sullivan,” said Dr.Derek Ren, CEO of Viva Biotech (Shanghai) Ltd. “This recognition validates our vision of building a truly integrated platform that unites AI-driven drug discovery (AIDD) with structure-based drug design (SBDD). The company’s AI platform is transforming the once-impossible into achievable breakthroughs. In future, we will continue accelerate the pace of AI-driven drug discovery and development and lead in a new era of scientific innovation.”

Viva Biotech’s unwavering commitment to client experience further enhances its global position. By offering flexible collaboration models and milestone-based agreements while ensuring full ownership of intellectual property for its partners, the company delivers clear value and fosters long-term trust. Its integrated service capabilities not only reduce project risks but also empower clients to explore emerging modalities with confidence, speed, and scientific rigor.

Frost & Sullivan commends Viva Biotech for setting a benchmark in technological innovation, strategic execution, and customer-centric growth. The company’s AI-first methodology, supported by world-class expertise in structural biology and preclinical experimentation, is shaping the evolution of integrated intelligent drug discovery and enabling measurable outcomes across therapeutic areas.

Each year, Frost & Sullivan presents the Technology Innovation Leadership recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. This recognition celebrates forward-looking organizations that are redefining their industries through transformative innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.

Contact us: Start the discussion.

Contact:

Tarini Singh
E: Tarini.Singh@frost.com 

About Viva Biotech

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

To learn more about Viva Biotech, please visit https://www.vivabiotech.com or contact at marketing@vivabiotech.com.